STOCK TITAN

Grindr to Participate in the Clinton Global Initiative 2026 Annual Meeting

Grindr’s CEO will speak on HIV prevention at the CGI 2026 Annual Meeting, where the company is also a listed sponsor.

(Neutral)
(Neutral)
Tags
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

LOS ANGELES--(BUSINESS WIRE)-- Grindr Inc. (NYSE: GRND), the Global Gayborhood in Your Pocket™, today announced that George Arison, Grindr's Chairman and Chief Executive Officer, will speak on the mainstage at the Clinton Global Initiative (CGI) 2026 Annual Meeting in New York, NY. Arison will appear on a featured panel, "Getting Disruption Right," on Wednesday, September 23, 2026, at 8:45 AM ET, where he will discuss the company’s commitment to HIV prevention.

Grindr is a sponsor of the CGI 2026 Annual Meeting, which convenes leaders across business, government, and civil society to advance action on global challenges.

A live webcast of the session will be available at https://clintonglobal.org/2026.

About Grindr Inc.

With 15 million average monthly active users, Grindr has grown to become the Global Gayborhood in Your Pocket™, on a mission to make a world where the lives of our global community are free, equal, and just. Available in 190 countries and territories, Grindr is often the primary way for its users to connect, express themselves, and discover the world around them. Since 2015, Grindr for Equality has advanced human rights, health, and safety for millions of LGBTQ+ people in partnership with organizations in every region of the world. Grindr has offices in West Hollywood, the Bay Area, Chicago, and New York. The Grindr app is available on the App Store and Google Play.

Investors:
IR@grindr.com

Media:
Press@grindr.com

Source: Grindr Inc.

Key Terms

hiv medical
Human immunodeficiency virus (HIV) is a virus that gradually damages the body's infection-fighting system and can lead to serious illness if not treated. For investors, HIV matters because progress or setbacks in tests, treatments, or vaccines can change demand for medicines, affect regulatory approvals and patent value, and shift healthcare spending—similar to how a major technology breakthrough can reshape an entire industry’s market prospects.

Keep reading